142 related articles for article (PubMed ID: 37670264)
21. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
22. PET/CT-Guided Tissue Sampling in Patients With a Failed or Inconclusive CT-Guided Procedure: Outcomes and Contributing Factors.
Kumar R; Sharma A; Thulkar S; Iyer VK; Sharma A
Clin Nucl Med; 2020 Aug; 45(8):581-587. PubMed ID: 32558712
[TBL] [Abstract][Full Text] [Related]
23. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.
Lei W; Zeng H; Zeng DX; Zhang B; Zhu YH; Jiang JH; Huang JA
Br J Radiol; 2016; 89(1057):20150695. PubMed ID: 26529231
[TBL] [Abstract][Full Text] [Related]
24. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
Venkatesan AM; Kadoury S; Abi-Jaoudeh N; Levy EB; Maass-Moreno R; Krücker J; Dalal S; Xu S; Glossop N; Wood BJ
Radiology; 2011 Sep; 260(3):848-56. PubMed ID: 21734159
[TBL] [Abstract][Full Text] [Related]
25. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
[TBL] [Abstract][Full Text] [Related]
27. 18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies.
Stefanidis K; Bellos I; Konstantelou E; Yusuf G; Hardavella G; Jacob T; Goldman A; Senbanjo T; Vlahos I
Eur J Radiol; 2024 Feb; 171():111315. PubMed ID: 38237515
[TBL] [Abstract][Full Text] [Related]
28.
Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
[TBL] [Abstract][Full Text] [Related]
29. The value of endobronchial ultrasound-guided transbronchial needle aspiration, 18-fluorodeoxyglucose positron emission tomography/computed tomography, and ultrasonography imaging techniques in the diagnosis of mediastinal and/or hilar malignant, anthracotic, and other benign lymph nodes.
Korkmaz C; Demirbas S; Vatansev H
Medicine (Baltimore); 2021 Feb; 100(7):e24728. PubMed ID: 33607816
[TBL] [Abstract][Full Text] [Related]
30. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
31. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
32. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
33. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
[TBL] [Abstract][Full Text] [Related]
34. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT.
Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX
Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a diagnostic
Lim CH; Seok HY; Hyun SH; Moon SH; Cho YS; Lee KH; Kim BT; Choi JY
Clin Radiol; 2019 Mar; 74(3):207-215. PubMed ID: 30638733
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
[TBL] [Abstract][Full Text] [Related]
38. PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results.
Cerci JJ; Bogoni M; Cerci RJ; Masukawa M; Neto CCP; Krauzer C; Fanti S; Sakamoto DG; Barreiros RB; Nanni C; Vitola JV
J Nucl Med; 2021 Aug; 62(8):1057-1061. PubMed ID: 33384323
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Radiation Exposure to the Patients Undergoing Positron Emission Tomography/Computed Tomography-Guided Biopsies.
Deva K; Rana N; Kumar R; Mittal BR
Indian J Nucl Med; 2022; 37(1):23-28. PubMed ID: 35478672
[TBL] [Abstract][Full Text] [Related]
40. Is
Zeng Y; Li M; Chen S; Lin L; Li S; He J; Wang J
Arthritis Res Ther; 2019 Dec; 21(1):282. PubMed ID: 31831053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
